0

Close
 
Upcoming Allied Market Research
2023
Gas Pharyngitis Diagnostics Market

GAS Pharyngitis Diagnostics Market

by Product Type (Rapid Test Kit, Culture Test,  PCR-based Test) and by End User (Hospitals, Diagnostic Laboratories, Physician Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Diagnostics and Biotech
Report Code: A13345
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Gas Pharyngitis Diagnostics Market

Request Now !

Group A streptococcus (GAS) pharyngitis, also known as strep throat, is a bacterial infection that occurs at the back of throat, including the tonsils. It is common among young infants and adult geriatric population, and occurs majorly at the end of winter season. Common symptoms associated with the infection include fever, sore throat, abdominal pain, nausea, vomiting, red eyes, and diarrhea. Strep throat is a communicable disease caused as a result of exposure with an infected person. Therefore, places with high footfall such as schools and military academies are likely to witness most transmission. Traditional diagnostic include a throat culture with a higher sensitivity and a rapid strep test, which comes with the advantage of quick results.

COVID-19 Impact Analysis

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

At the early phase of the COVID-19 pandemic, there was no availability of specific diagnostic tests to detect the disease in patients. Alternative diagnostic tests were used initially but were not much effective. This unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their COVID-19 diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced COVID-19 diagnostics kits into local as well as global markets. These players achieved an edge over other diagnostics players capitalizing on the opportunity from demand for COVID-19 diagnostic tests, which, in turn, helps them in maintaining their revenues in such a crisis.

Owing to such factors, COVID 19 is expected to have a significant impact on the GAS pharyngitis diagnostics market.

Top Impacting Factors

  • Increase in the number of death incidents due to rheumatic heart disease especially in industrialized regions is anticipated to drive market growth. The disease is caused by exposure to group A streptococcus bacteria, which leads to scarlet fever and strep throat.
  • Significant grassroots work being carried out in diagnostics industry coupled with an influx of foreign direct investments and robust governmental policies is further promising great results for GAS pharyngitis market.
  • Rising awareness with respect to new age diagnostic techniques launched and still under design & development phase coupled with consumer shift toward advanced healthcare mechanisms from the traditional means is likely to provide much required impetus for the growth of GAS pharyngitis diagnostic market. Countries with robust purchasing power parity and favorable reimbursements are most likely to experience consumer shifts.
  • However, the market is likely to be hampered, owing to wide array of challenges associated with GA pharyngitis diagnosis. Among them, providing accurate, specific, and efficient diagnostic results is of the foremost importance.
  • Additionally, lack of awareness on recently developed diagnostic techniques coupled with wide spectrum of misconceptions rumored in third world economies and regions with disturbed politico-legal dynamics may hamper the market penetration.
  • Shift of total healthcare infrastructure toward battling COVID-19 and its effects have resulted in delays in new diagnostic product launches and cancellations in clinical trials. This may further hamper current growth of GAS pharyngitis diagnostic kits market.

Key Market Trends

  • North America is anticipated to witness dominance in GAS pharyngitis diagnostic kit market, owing to large number of recent incidents of the disease being reported in the region coupled with policy shift toward quick design and development of new age therapeutic/diagnostic mechanisms.
  • Doctors and Researchers at Saint Michael’s Medical Center are studying new cased of co-occurrence of GAS pharyngitis and COVID-19 being reported in the U.S. Increasing number of cases of COVID-19 patients suffering from upper respiratory disorders are being reported simultaneously in the region which are of great concern to the healthcare industry.
  • Clinical labs around the globe are working on the prospect of assimilating molecular assays to eliminate the need for supplement testing.

Key Benefits of the Report

  • This study presents the analytical depiction of the GAS pharyngitis diagnostics industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the GAS pharyngitis diagnostics market share.
  • The current market is quantitatively analyzed to highlight the market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the GAS Pharyngitis Diagnostics Report

  • Which are the leading players active in the GAS pharyngitis diagnostics market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the GAS pharyngitis diagnostics market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What are the impacts of COVID-19 in the industry?
  • What is GAS pharyngitis diagnostics?
  • What is the GAS pharyngitis diagnostics market prediction in the future?
  • What are the current trends and predicted trends?

 GAS Pharyngitis Diagnostics Market Report Highlights

Aspects Details
By Product Type
  • Rapid Test Kit
  • Culture Test
  •  PCR-based Test
By End User
  • Hospitals
  • Diagnostic Laboratories
  • Physician Clinics
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Meridian Bioscience, Inc., Abbott Laboratories, Beckman Coulter, Inc. (Danaher), Mckesson CONSULT, DiaSorin S.p.A., Quidel Corporatiion, Sekisui Diagnostics, F. Hoffmann-La Roche Ltd, BD, Multibrands International Ltd.
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: GAS PHARYNGITIS DIAGNOSTICS MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Rapid Test Kit

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Culture Test

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4.  PCR-based Test

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: GAS PHARYNGITIS DIAGNOSTICS MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospitals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Diagnostic Laboratories

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Physician Clinics

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Others

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: GAS PHARYNGITIS DIAGNOSTICS MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product Type

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Gas Pharyngitis Diagnostics Market

        • 6.2.5.1. Market Size and Forecast, By Product Type
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada Gas Pharyngitis Diagnostics Market

        • 6.2.6.1. Market Size and Forecast, By Product Type
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico Gas Pharyngitis Diagnostics Market

        • 6.2.7.1. Market Size and Forecast, By Product Type
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product Type

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Gas Pharyngitis Diagnostics Market

        • 6.3.5.1. Market Size and Forecast, By Product Type
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany Gas Pharyngitis Diagnostics Market

        • 6.3.6.1. Market Size and Forecast, By Product Type
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy Gas Pharyngitis Diagnostics Market

        • 6.3.7.1. Market Size and Forecast, By Product Type
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain Gas Pharyngitis Diagnostics Market

        • 6.3.8.1. Market Size and Forecast, By Product Type
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK Gas Pharyngitis Diagnostics Market

        • 6.3.9.1. Market Size and Forecast, By Product Type
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia Gas Pharyngitis Diagnostics Market

        • 6.3.10.1. Market Size and Forecast, By Product Type
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe Gas Pharyngitis Diagnostics Market

        • 6.3.11.1. Market Size and Forecast, By Product Type
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product Type

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Gas Pharyngitis Diagnostics Market

        • 6.4.5.1. Market Size and Forecast, By Product Type
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan Gas Pharyngitis Diagnostics Market

        • 6.4.6.1. Market Size and Forecast, By Product Type
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India Gas Pharyngitis Diagnostics Market

        • 6.4.7.1. Market Size and Forecast, By Product Type
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea Gas Pharyngitis Diagnostics Market

        • 6.4.8.1. Market Size and Forecast, By Product Type
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia Gas Pharyngitis Diagnostics Market

        • 6.4.9.1. Market Size and Forecast, By Product Type
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand Gas Pharyngitis Diagnostics Market

        • 6.4.10.1. Market Size and Forecast, By Product Type
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia Gas Pharyngitis Diagnostics Market

        • 6.4.11.1. Market Size and Forecast, By Product Type
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia Gas Pharyngitis Diagnostics Market

        • 6.4.12.1. Market Size and Forecast, By Product Type
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific Gas Pharyngitis Diagnostics Market

        • 6.4.13.1. Market Size and Forecast, By Product Type
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product Type

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Gas Pharyngitis Diagnostics Market

        • 6.5.5.1. Market Size and Forecast, By Product Type
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa Gas Pharyngitis Diagnostics Market

        • 6.5.6.1. Market Size and Forecast, By Product Type
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia Gas Pharyngitis Diagnostics Market

        • 6.5.7.1. Market Size and Forecast, By Product Type
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE Gas Pharyngitis Diagnostics Market

        • 6.5.8.1. Market Size and Forecast, By Product Type
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina Gas Pharyngitis Diagnostics Market

        • 6.5.9.1. Market Size and Forecast, By Product Type
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA Gas Pharyngitis Diagnostics Market

        • 6.5.10.1. Market Size and Forecast, By Product Type
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Quidel Corporatiion

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. BD

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Abbott Laboratories

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. F. Hoffmann-La Roche Ltd

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Beckman Coulter, Inc. (Danaher)

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Meridian Bioscience, Inc.

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. DiaSorin S.p.A.

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Sekisui Diagnostics

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Mckesson CONSULT

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Multibrands International Ltd.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL GAS PHARYNGITIS DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL GAS PHARYNGITIS DIAGNOSTICS MARKET FOR RAPID TEST KIT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL GAS PHARYNGITIS DIAGNOSTICS MARKET FOR CULTURE TEST, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL GAS PHARYNGITIS DIAGNOSTICS MARKET FOR  PCR-BASED TEST, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL GAS PHARYNGITIS DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL GAS PHARYNGITIS DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL GAS PHARYNGITIS DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL GAS PHARYNGITIS DIAGNOSTICS MARKET FOR PHYSICIAN CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL GAS PHARYNGITIS DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL GAS PHARYNGITIS DIAGNOSTICS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA GAS PHARYNGITIS DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. NORTH AMERICA GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 14. U.S. GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 15. U.S. GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 16. CANADA GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 17. CANADA GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 18. MEXICO GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 19. MEXICO GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 20. EUROPE GAS PHARYNGITIS DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. EUROPE GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 22. EUROPE GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. FRANCE GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 24. FRANCE GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 25. GERMANY GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 26. GERMANY GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. ITALY GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 28. ITALY GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. SPAIN GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 30. SPAIN GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 31. UK GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 32. UK GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. RUSSIA GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 34. RUSSIA GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 35. REST OF EUROPE GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 36. REST OF EUROPE GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. ASIA-PACIFIC GAS PHARYNGITIS DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 38. ASIA-PACIFIC GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 39. ASIA-PACIFIC GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. CHINA GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 41. CHINA GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. JAPAN GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 43. JAPAN GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 44. INDIA GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 45. INDIA GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. SOUTH KOREA GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 47. SOUTH KOREA GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. AUSTRALIA GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 49. AUSTRALIA GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 50. THAILAND GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 51. THAILAND GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. MALAYSIA GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 53. MALAYSIA GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 54. INDONESIA GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 55. INDONESIA GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 56. REST OF ASIA PACIFIC GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 57. REST OF ASIA PACIFIC GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 58. LAMEA GAS PHARYNGITIS DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 59. LAMEA GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 60. LAMEA GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. BRAZIL GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 62. BRAZIL GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. SOUTH AFRICA GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH AFRICA GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. SAUDI ARABIA GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 66. SAUDI ARABIA GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. UAE GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 68. UAE GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 69. ARGENTINA GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 70. ARGENTINA GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. REST OF LAMEA GAS PHARYNGITIS DIAGNOSTICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 72. REST OF LAMEA GAS PHARYNGITIS DIAGNOSTICS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 73. QUIDEL CORPORATIION: KEY EXECUTIVES
  • TABLE 74. QUIDEL CORPORATIION: COMPANY SNAPSHOT
  • TABLE 75. QUIDEL CORPORATIION: OPERATING SEGMENTS
  • TABLE 76. QUIDEL CORPORATIION: PRODUCT PORTFOLIO
  • TABLE 77. QUIDEL CORPORATIION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 78. BD: KEY EXECUTIVES
  • TABLE 79. BD: COMPANY SNAPSHOT
  • TABLE 80. BD: OPERATING SEGMENTS
  • TABLE 81. BD: PRODUCT PORTFOLIO
  • TABLE 82. BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 83. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 84. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 85. ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 86. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 87. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 88. F. HOFFMANN-LA ROCHE LTD: KEY EXECUTIVES
  • TABLE 89. F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
  • TABLE 90. F. HOFFMANN-LA ROCHE LTD: OPERATING SEGMENTS
  • TABLE 91. F. HOFFMANN-LA ROCHE LTD: PRODUCT PORTFOLIO
  • TABLE 92. F. HOFFMANN-LA ROCHE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 93. BECKMAN COULTER, INC. (DANAHER): KEY EXECUTIVES
  • TABLE 94. BECKMAN COULTER, INC. (DANAHER): COMPANY SNAPSHOT
  • TABLE 95. BECKMAN COULTER, INC. (DANAHER): OPERATING SEGMENTS
  • TABLE 96. BECKMAN COULTER, INC. (DANAHER): PRODUCT PORTFOLIO
  • TABLE 97. BECKMAN COULTER, INC. (DANAHER): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 98. MERIDIAN BIOSCIENCE, INC.: KEY EXECUTIVES
  • TABLE 99. MERIDIAN BIOSCIENCE, INC.: COMPANY SNAPSHOT
  • TABLE 100. MERIDIAN BIOSCIENCE, INC.: OPERATING SEGMENTS
  • TABLE 101. MERIDIAN BIOSCIENCE, INC.: PRODUCT PORTFOLIO
  • TABLE 102. MERIDIAN BIOSCIENCE, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 103. DIASORIN S.P.A.: KEY EXECUTIVES
  • TABLE 104. DIASORIN S.P.A.: COMPANY SNAPSHOT
  • TABLE 105. DIASORIN S.P.A.: OPERATING SEGMENTS
  • TABLE 106. DIASORIN S.P.A.: PRODUCT PORTFOLIO
  • TABLE 107. DIASORIN S.P.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108. SEKISUI DIAGNOSTICS: KEY EXECUTIVES
  • TABLE 109. SEKISUI DIAGNOSTICS: COMPANY SNAPSHOT
  • TABLE 110. SEKISUI DIAGNOSTICS: OPERATING SEGMENTS
  • TABLE 111. SEKISUI DIAGNOSTICS: PRODUCT PORTFOLIO
  • TABLE 112. SEKISUI DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. MCKESSON CONSULT: KEY EXECUTIVES
  • TABLE 114. MCKESSON CONSULT: COMPANY SNAPSHOT
  • TABLE 115. MCKESSON CONSULT: OPERATING SEGMENTS
  • TABLE 116. MCKESSON CONSULT: PRODUCT PORTFOLIO
  • TABLE 117. MCKESSON CONSULT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. MULTIBRANDS INTERNATIONAL LTD.: KEY EXECUTIVES
  • TABLE 119. MULTIBRANDS INTERNATIONAL LTD.: COMPANY SNAPSHOT
  • TABLE 120. MULTIBRANDS INTERNATIONAL LTD.: OPERATING SEGMENTS
  • TABLE 121. MULTIBRANDS INTERNATIONAL LTD.: PRODUCT PORTFOLIO
  • TABLE 122. MULTIBRANDS INTERNATIONAL LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL GAS PHARYNGITIS DIAGNOSTICS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL GAS PHARYNGITIS DIAGNOSTICS MARKET
  • FIGURE 3. SEGMENTATION GAS PHARYNGITIS DIAGNOSTICS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN GAS PHARYNGITIS DIAGNOSTICS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALGAS PHARYNGITIS DIAGNOSTICS MARKET
  • FIGURE 11. GAS PHARYNGITIS DIAGNOSTICS MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. GAS PHARYNGITIS DIAGNOSTICS MARKET FOR RAPID TEST KIT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. GAS PHARYNGITIS DIAGNOSTICS MARKET FOR CULTURE TEST, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. GAS PHARYNGITIS DIAGNOSTICS MARKET FOR  PCR-BASED TEST, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. GAS PHARYNGITIS DIAGNOSTICS MARKET SEGMENTATION, BY BY END USER
  • FIGURE 16. GAS PHARYNGITIS DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. GAS PHARYNGITIS DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. GAS PHARYNGITIS DIAGNOSTICS MARKET FOR PHYSICIAN CLINICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. GAS PHARYNGITIS DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 24. COMPETITIVE DASHBOARD
  • FIGURE 25. COMPETITIVE HEATMAP: GAS PHARYNGITIS DIAGNOSTICS MARKET
  • FIGURE 26. Top player positioning, 2022
  • FIGURE 27. QUIDEL CORPORATIION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 28. QUIDEL CORPORATIION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 29. QUIDEL CORPORATIION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 30. BD: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 31. BD: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 32. BD: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 33. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. F. HOFFMANN-LA ROCHE LTD: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. BECKMAN COULTER, INC. (DANAHER): NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. BECKMAN COULTER, INC. (DANAHER): REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. BECKMAN COULTER, INC. (DANAHER): REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. MERIDIAN BIOSCIENCE, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. MERIDIAN BIOSCIENCE, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. MERIDIAN BIOSCIENCE, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. DIASORIN S.P.A.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. DIASORIN S.P.A.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. DIASORIN S.P.A.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. SEKISUI DIAGNOSTICS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. SEKISUI DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. SEKISUI DIAGNOSTICS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. MCKESSON CONSULT: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. MCKESSON CONSULT: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. MCKESSON CONSULT: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. MULTIBRANDS INTERNATIONAL LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. MULTIBRANDS INTERNATIONAL LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. MULTIBRANDS INTERNATIONAL LTD.: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Gas Pharyngitis Diagnostics Market

Start reading.
This Report and over 67,068+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers